Please login to the form below

Not currently logged in
Email:
Password:

Makara Health launches compliance training division

Collaborates with Dr Nick Broughton on the new programme

Learning and development

Healthcare communications and education agency Makara Health has launched a new ethics and code compliance training as a division of its learning and development portfolio.

The move is a partnership with ethics and compliance trainer Dr Nick Broughton and the agency aims to “focus on tapping into something deeper than just upskilling” so that it can “truly effect change - either to a situation or personal ability”.

Makara Health founder and managing director Louise Sharp said: “At Makara Health, our learning and development programmes have a reputation for being thought provoking and a bit different.

“Our new Ethics and Code Compliance division with Dr Nick Broughton fits entirely with this ethos.”

From May, Makara Health and Broughton will offer a range of courses on compliance within the ABPI and EFPIA codes of practice, aimed at audiences from senior managers to those involved with marketing materials.

Dr Broughton said: “ I know from client feedback that what I offer is different and engaging, which is why I chose to work with Makara as it aligns to their way of thinking.

“Attendees to my courses often find themselves bemused by actually enjoying compliance training. I work hard to make my sessions fun and interactive rather than a case of learning the ABPI Code by rote.”

Alongside the programme, Broughton is offering a specific course for pharmaceutical physicians covering topics such as clinical research, drug safety, and digital and social media in relation to code compliance.

Article by
Gemma Jones

3rd April 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics